SA
PBLS

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.6 · elevated volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

Operating Cash Flow

-$124.99M

TTM · Period ending: · USD

PBLS logo

PBLS Operating Cash Flow

Latest reported-$124.99M
PBLS Operating Cash Flow (-$103.61M → -$124.99M)
High-resolution chart · PNG

What is operating cash flow?

Cash generated from core business operations.

Compare operating cash flow

PBLS operating cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Parabilis Medicines, Inc. Operating Cash Flow — Annual fiscal periods (USD)
Period endingOperating Cash Flow (USD)
-123,713,000
-103,613,000

Frequently asked questions: PBLS operating cash flow

What is Parabilis Medicines, Inc. (PBLS)'s current operating cash flow?

Parabilis Medicines, Inc. (PBLS)'s latest reported operating cash flow (TTM) is -$124.99M as of Sep 30, 2026. Cash generated from core business operations.

How much historical operating cash flow data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s operating cash flow, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's operating cash flow to peers or set an alert?

You can compare PBLS's operating cash flow directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.